Example: Heart Attack

Clinical Trials on Bacterial Infections

Total 395 results

NCT04517695

Recruiting

Blood Volume Assessment in COVID-19 and Bacterial Sepsis

Conditions: Covid19, Acute Respiratory Distress Syndrome, Bacterial Sepsis, Bacterial Infections
NCT03925480

Active, not recruiting

Preventing Young Infant Infections Using Azithromycin in Labour (PreYIAL) Trial

Conditions: Bacterial Infections
NCT05498363

Completed

Bacteriophage Therapy of Difficult-to-treat Infections

Conditions: Bacterial Infections
NCT00353158

Completed

A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity

Conditions: Healthy Volunteers, Fungal Infections, Bacterial Infections
NCT05090475

Recruiting

The Implementation of Educational Interventions on the Prescribing of Antimicrobial Drugs in Primary Health Care

Conditions: Upper Respiratory Tract Infections, Acute Respiratory Tract Infection, Clostridium Difficile Infection, Viral Infection, Bacterial Infections
NCT04981860

Recruiting

Comparison of Conjunctival Antimicrobial Activity and Patient Comfort Between Topical Hypochlorous Acid (Avenova) and Betadine

Conditions: Eye Infections, Bacterial
NCT05293418

Recruiting

Incidence of Colonization by Multidrug-resistant Organisms in Mechanically Ventilated Patients With Severe COVID-19

Conditions: COVID-19, Bacterial Infections, Colonization, Asymptomatic
NCT03671967

Recruiting

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Conditions: Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia
NCT05355350

Recruiting

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Conditions: Beta Lactam Resistant Bacterial Infection, Enterobacteriaceae Infections, Bacteremia
NCT04664075

Suspended

Predicting Severity and Disease Progression in Influenza-like Illness (Including COVID-19)

Conditions: Influenza, SARS (Severe Acute Respiratory Syndrome), Respiratory Viral Infection, Respiratory Tract Infections, Infection, Bacterial, Infection Viral, Covid19, RNA Virus Infections
NCT05475444

Completed

PLGA Nanoparticles Entrapping Ciprofloxacin to Treat E-Fecalis Infections in Endodontics

Conditions: Bacterial Infections Oral
NCT02572791

Active, not recruiting

Staph Household Intervention for Eradication (SHINE)

Conditions: Skin and Subcutaneous Tissue Bacterial Infections, Staphylococcus Aureus, MRSA - Methicillin Resistant Staphylococcus Aureus Infection
NCT05088421

Recruiting

A First in Human Study of the Safety and Tolerability of Single and Multiple Doses of BWC0977 in Healthy Volunteers

Conditions: Infectious Diseases, Bacterial Infections
NCT00945152

Recruiting

Effects of MRSA Bactericidal Gel To Promote Healing and Eliminate MRSA in cSSTI Vancogel(TM)

Conditions: Bacterial Infections, Wounds
NCT04380207

Recruiting

P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV

Conditions: Bacterial Infections
NCT04808414

Completed

SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers

Conditions: Bacterial Infections
NCT05340257

Not yet recruiting

A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS

Conditions: Infections, Bacterial
NCT03176134

Recruiting

A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018)

Conditions: Acute Bacterial Skin and Skin Structure Infections
NCT05456906

Recruiting

Avoidable Hospitalizations/ Emergency Department Visits- Systematic Review and Meta-synthesis of Qualitative Research

Conditions: Diabetes, Heart Failure, Chronic Obstructive Pulmonary Disease, Asthma, Hypertension, Urinary Tract Infections, Pneumonia, Bacterial
NCT03982030

Not yet recruiting

Dalbavancin Outpatient Pilot

Conditions: Gram-Positive Bacterial Infections, Soft Tissue Infections
NCT03992703

Active, not recruiting

Clinical Impact of Rapid AST Directly From Blood Cultures

Conditions: Bacterial Infections
NCT05217537

Recruiting

Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections

Conditions: Bacterial Infections
NCT04215991

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants

Conditions: Gram-negative Bacterial Infections, Hospital Acquired Bacterial Pneumonia (HABP), Complicated Urinary Tract Infection (cUTI), Ventilator Associated Bacterial Pneumonia (VABP)
NCT04785924

Recruiting

Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections

Conditions: Carbapenem-Resistant Enterobacteriaceae Infection, KPC, Gram-Negative Bacterial Infections, Antibiotic Resistant Infection
NCT02814916

Recruiting

Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA

Conditions: Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections, Staphylococcal Skin Infections

Clinical Trials on Bacterial Infections

Medical Conditions

Sponsors and Collaborators

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations